The adverse reactions to contrast media during percutaneous coronary interventions; keep in mind the non-idiosyncratic reactions.

I. Kaplanis, G. Michas, Sofia Arapi, George Karvelas, A. Trikas
{"title":"The adverse reactions to contrast media during percutaneous coronary interventions; keep in mind the non-idiosyncratic reactions.","authors":"I. Kaplanis, G. Michas, Sofia Arapi, George Karvelas, A. Trikas","doi":"10.2015/HC.V14I1.848","DOIUrl":null,"url":null,"abstract":"Iodinated contrast media are of paramount importance in the field of modern interventional cardiology. Although iodinated contrast media have an overall good safety profile, severe or life-threatening reactions can also occur. Herein, we report the case of a 74-year-old female patient who presented with non-ST elevation myocardial infarction and underwent a successful percutaneous coronary intervention. Shortly after the procedure the patient developed the full-blown clinical picture of an iodinated contrast media adverse reaction that was timely recognized and treated. The two types of adverse reactions to iodinated contrast media during a percutaneous coronary intervention are being discussed. A high level of clinical suspicion is warranted to ensure prompt recognition and appropriate management. I n T R o d u C T I o n Organic radiographic iodinated contrast media (ICM) have been among the most commonly used agents in the modern era of medicine and have become of paramount importance in the field of interventional cardiology. Although ICM have a good safety record, with usually mild and self-limited adverse effects, severe or life-threatening reactions can also occur. Therefore, physicians should be able to immediately recognize and treat the severe reactions of ICM.","PeriodicalId":91266,"journal":{"name":"Hospital chronicles = Nosokomeiaka chronika","volume":"14 1","pages":"24-26"},"PeriodicalIF":0.0000,"publicationDate":"2019-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hospital chronicles = Nosokomeiaka chronika","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2015/HC.V14I1.848","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Iodinated contrast media are of paramount importance in the field of modern interventional cardiology. Although iodinated contrast media have an overall good safety profile, severe or life-threatening reactions can also occur. Herein, we report the case of a 74-year-old female patient who presented with non-ST elevation myocardial infarction and underwent a successful percutaneous coronary intervention. Shortly after the procedure the patient developed the full-blown clinical picture of an iodinated contrast media adverse reaction that was timely recognized and treated. The two types of adverse reactions to iodinated contrast media during a percutaneous coronary intervention are being discussed. A high level of clinical suspicion is warranted to ensure prompt recognition and appropriate management. I n T R o d u C T I o n Organic radiographic iodinated contrast media (ICM) have been among the most commonly used agents in the modern era of medicine and have become of paramount importance in the field of interventional cardiology. Although ICM have a good safety record, with usually mild and self-limited adverse effects, severe or life-threatening reactions can also occur. Therefore, physicians should be able to immediately recognize and treat the severe reactions of ICM.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
经皮冠状动脉介入治疗期间对造影剂的不良反应;请记住非特殊反应。
碘造影剂在现代介入心脏病学领域具有至关重要的作用。虽然碘造影剂总体上具有良好的安全性,但也可能发生严重或危及生命的反应。在此,我们报告一例74岁的女性患者,她表现为非st段抬高型心肌梗死,并成功接受了经皮冠状动脉介入治疗。手术后不久,患者出现了碘化造影剂不良反应的全面临床表现,并得到了及时的认识和治疗。本文讨论了经皮冠状动脉介入治疗中碘造影剂的两种不良反应。临床高度怀疑是必要的,以确保及时识别和适当的管理。有机放射碘化造影剂(ICM)是现代医学中最常用的造影剂之一,在介入心脏病学领域具有至关重要的作用。虽然ICM具有良好的安全记录,通常具有轻微和自限性的不良反应,但也可能发生严重或危及生命的反应。因此,医生应该能够立即识别和治疗ICM的严重反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Efficacy of Infliximab after Failure of Subcutaneous Anti-TNF Agents in Patients with Moderate to Severe Ulcerative Colitis Hypocholesterolemia: a blessing or a problem? Physiotherapy in a Burn Patient Admitted in Intensive Care Unit Red Blood Cell Unit Utilization in the ICU: Evidence and Confidence Oncology News / Literature Review / July-December 2019
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1